Oct 29, 2026
Jake McCarley, Co-Founder and CEO of Alluvium, highlights how chatbots have evolved from simple question-and-answer functions to actively helping patients navigate complex health systems. The Alluvium platform integrates existing EMR systems with real-time information to provide intelligent patient support,...
Oct 29, 2026
Jake McCarley, Co-Founder and CEO of Alluvium, highlights how chatbots have evolved from simple question-and-answer functions to actively helping patients navigate complex health systems. The Alluvium platform integrates existing EMR systems with real-time information to provide intelligent patient support,...
Oct 29, 2026
Dr. Christopher Moertel, Global Head of Clinical Development at Healx, describes how AI is transforming the discovery and development of treatments for rare diseases. Healx is using computational chemistry and AI to match disease pathways with existing compounds to identify drugs that may be repurposed or combined for...
Oct 29, 2026
Dr. Christopher Moertel, Global Head of Clinical Development at Healx, describes how AI is transforming the discovery and development of treatments for rare diseases. Healx is using computational chemistry and AI to match disease pathways with existing compounds to identify drugs that may be repurposed or combined for...
Oct 28, 2026
Dr. Aneel Nimba, Medical Director at Faron Pharmaceuticals, discusses the company's innovative approach to treating higher risk myelodysplastic syndromes, a group of rare blood cancers, with its lead drug candidate that targets the CLEVER-1 receptor which controls the tumor microenvironment. This first-in-class...